Industry
Featured experience
Amgen $28.5 billion Horizon Therapeutics acquisition financing
We advised the lender parties on the financing
Forbion European Acquisition $138 million combination with enGene
We advised Forbion European Acquisition on its de-SPAC transaction
Bausch + Lomb $630 million IPO
We are advising Bausch Health on the separation of its eye health business into a new public company, Bausch + Lomb
Trial victory in patent infringement case for Magnolia Medical Technologies
We served as lead trial counsel for Magnolia Medical in an action against its sole competitor
Greenway Health $375 million refinancing
We advised the administrative agent, arrangers and bookrunners on the financing
Immatics $201 million follow-on offering
We advised Immatics on the offering of shares
IDEAYA Biosciences $350 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Alector $75 million stock offering
The common stock is listed on the Nasdaq Global Select Market
Sun Pharmaceutical enters into merger agreement with Taro Pharmaceutical
We are advising Sun Pharma on the transaction
Roche $295 million acquisition of LumiraDx's point of care technology platform
We are advising Roche on the acquisition
OPKO Health $230 million convertible senior notes offering
The 3.75% convertible notes are due 2029
Auna $550 million secured term loan refinancing
We advised Auna on the transaction
Solid Biosciences $109 million private placement
The PIPE includes common stock and pre-funded warrants
Olema Pharmaceuticals $150 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market